NLRP3 and breast neoplasm: The obtained results contribute to the understanding of the NLRP3 inflammasome pathway in the context of breast pathologies and approve the ability of PTX-enriched GF-based scaffolds to counteract the growth of breast tumor cells by inducing NLRP3 inflammasome activation and pyroptosis cell death, acting as potential therapeutic scaffolds for breast cancer therapy.